The in vitro effect of pegylated recombinant human megakaryocyte growth and development factor (PEG rHuMGDF) on megakaryopoiesis in normal subjects and patients with myelodysplasia and acute myeloid leukaemia

British Journal of Haematology

Volumn 99, Issue 1, 1997, Pages 139-146

  Adams, J A ^a   Liu Yin, J A ^a   Brereton, M L ^a   Briggs, M ^a   Burgess, R ^a   Hyde, K ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

AML; MDS; Megakaryopoiesis; PEG rHuMGDF

Indexed keywords

MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN TISSUE; MEGAKARYOPOIESIS; MYELODYSPLASIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 9844268495     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.3543166.x     Document Type: Article

References (28)

1. Akahori, H., Shibuya, K., Obuchi, M., Nishizawa, Y., Tsuji, A., Kabaya, K., Kusaka, M., Ohashi, H., Tsumura, H., Kato, T. & Miyazaki, H. (1996) Effect of recombinant human thrombopoietin in nonhuman primates with chemotherapy-induced thrombocytopenia. British Journal of Haematology, 94, 722-728.
2. Bartley, T.D., Bogenberger, J., Hunt, P., Li, Y.S., Lu, H.S., Martin, F., Chang, M-S., Samal, B., Nichol, J.L., Swift, S., Johnson, M.J., Hsu, R-Y., Parker, V.P., Suggs, S., Skrine, J.D., Merewether, L.A., Clogston, C., Hsu, E., Hokom, M.M., Homkohl, A., Choi, E., Pangelinan, M., Sun, Y., Mar, V., McNinch, J., Simonet, L. Jacobsen, F., Xie, C., Shutter, J., Chute, H., Basu, R., Selander, L., Trollinger, D., Sieu, L., Padilla, D., Trail, G., Elliott, G., Izumi, R., Covey, T., Crouse, J., Garcia, A., Xu, W., Del Castillo, J., Biron, J., Cole, S., Hu, M.C-T., Pacifici, R., Ponting, I., Saris, C., Wen, D., Yung, Y.P., Lin, H. & Bosselman, R.A. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell, 77, 1117-1124.
3. Basser, R.L., Rasko, J.E.J., Clarke, K., Cebon, J., Green, M.D., Hussein, S., Alt, C., Menchaca, D., Tomita, D., Marty, J., Fox, R.M. & Begley, C.G. (1996) Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet, 348, 1279-1281.
4. Broudy, V.C., Lin, N.L. & Kaushansky, K. (1995) Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood, 85, 1719-1726.
5. Burgess, R., Hyde, K., Lenehan, H., Brereton, M.L., Geary, C.G. & Liu Yin, J.A. (1995) Immunostaining of whole agar culture by APAAP. Clinical and Laboratory Haematology, 17, 65-70.
6. Debili, N., Wendling, F., Katz, A., Guichard, J., Breton-Gorius, J., Hunt, P. & Vainchenker, W. (1995) The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiate factor has both direct proliferative and differentiate activities on human megakaryocyte progenitors. Blood, 86, 2516-2525.
7. de Sauvage, F.J., Hass, P.E., Spencer, S.D., Malloy, B.E., Gurney, A.L., Spencer, S.A., Darbonne, W.C., Henzel, W.J., Wong, S.C., Kuang, W-J., Hultgren, B., Solberg, L.A., Jr, Goeddel, D.V. & Eaton, D.L. (1994) Stimulation of megakaryopoiesis and thrombopoiesis by the c-Mpl ligand. Nature, 369, 535-538.
8. D'Hondt, V., Humblet, Y., Guillaume, T., Baatout, S., Chatelain, C., Berliere, M., Longueville, J., Feyens, A.M., De Greve, J., Van Oosterom, A., Von Graffenreid, B., Donnez, J. & Symann, M. (1995) Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study. Blood, 85, 2347-2353.
9. Drexler, H.G. & Quentmeier, H. (1996) Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. Leukemia, 10, 1405-1421.
10. Fanucchi, M., Glaspy, J., Crawford, J., Garst, J., Figlin, R., Sheridan, W., Menchaca, D., Tomita, D., Ozer, H. & Harker, L. (1997) Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer. New England Journal of Medicine, 336, 404-409.
11. Farese, A.M., Hunt, P., Boone, T. & MacVittie, T.J. (1495) Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood, 86, 54-59.
12. Gordon, M.S., Nemunaitis, J., Hoffman, R., Paquette, R.L., Rosenfeld, C., Manfreda, S., Isaacs, R. & Nimer, S.D. (1995) A phase I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia. Blood, 85, 3066-3076.
13. Gordon, M.S., Worta, J., McCaskill-Stevens, W.J., Battiato, L.A., Loewy, J., Loesch, D., Breeden, E., Hoffman, R., Beach, K.J., Kuca, B., Kaye, J. & Sledge, G.W., Jr (1996) A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood, 87, 3615-3624.
14. Gurney, A.L., Carver-Moore, K., de Sauvage, F.J. & Moore, M.W. (1994) Thrombocytopenia in c-mpl deficient mice. Science, 265, 1445-1447.
15. Hellstrom-Lindberg, E. (1995) Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. British Journal of Haematology, 89, 67-71.
16. Hokom, M.M., Lacey, D., Kinstler, O.B., Choi, E., Kaufman, S., Faust, J., Rowan, C., Owyer, E., Nichol, J.L., Grasel, T., Wilson, J., Steinbrink, R., Hecht, R., Winters, D., Boone, T. & Hunt, P. (1995) Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood, 86, 4486-4492.
17. Kaushansky, K., Lok, S., Holly, R.D., Broudy, V.C., Lin, N., Balley, M.C., Forstrom, J.W., Buddle, M.M., Oort, P.J., Hagen, F.S., Roth, G.J., Papayannopoulou, T. & Foster, D.C. (1994) Promotion of megakaryocyte progenitor expansion and differentiation by the c-mpl ligand thrombopoietin. Nature, 369, 568-571.
18. Kuter, D.J., Beeler, D.L. & Rosenberg, R.D. (1994) The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proceedings of the National Academy of Sciences of the United Slates of America, 91, 11104-11108.
19. Lok, S., Kaushansky, K., Holly, R.D., Kuijper, J.L., Lofton-Day, C.E., Oort, P.J., Grant, F.J., Heipel, M.D., Burkhead, S.K., Kramer, J.M., Bell, L.A., Sprecher, C.A., Blumberg, H., Johnson, R., Prunkard, D., Ching Aft, D., Mathewes, S.L., Bailey, M.C., Forstrom, J.W., Buddle, M.M., Osborn, S.G., Evans, S.J., Sheppard, P.O., Presnell, S.R., O'Hara, P.J., Hagan, F.S., Roth, G.J. & Foster, D.C. (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature, 369, 565-568.
20. Matsumura, I., Kanakura, Y., Kato, T., Ikeda, H., Horikawa, Y., Ishikawa, J., Kitayama, H., Nishiura, T., Tomiyama, Y., Miyazaki, H. & Matsuzawa, Y. (1996) The biologic properties of recombinant human thrombopoietin in the proliferation and megakaryocytic differentiation of acute myeloblastic leukemia cells. Blood, 88, 3074-3082.
21. Matsumura, I., Kanakura, Y., Kato, T., Ikeda, H., Ishikawa, J., Horikawa, Y., Hashimoto, K., Moriyama, Y., Tsujimura, T., Nishiura, T., Miyazaki, H. & Matsuzawa, Y. (1995) Growth response of acute myelobastic leukemia cells to recombinant human thrombopoietin. Blood, 86, 703-709.
22. Motoji, T., Takanashi, M., Motomura, S., Wang, Y.H., Shiozaki, H., Aoyama, M. & Mizoguchi, H. (1996) Growth stimulatory effect of thrombopoietin on the blast cells of acute myelogenous leukaemia. British Journal of Haematology, 94, 513-516.
23. Nagler, A., MacKichan, M.L., Negrin, R.S., Donlon, T. & Greenberg, P.L. (1995) Effects of granulocyte colony-stimulating factor therapy on in vitro hemopoiesis in myelodysplastic syndromes. Leukemia, 9, 30-39.
24. Negrin, R.S., Stein, R., Vardiman, J., Doherty, K., Cornwall, J., Krantz, S. & Greenberg, P.L. (1993) Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte-macrophage colony-stimulating factor in combination with erythropoietin. Blood, 82, 757-743.
25. Schrezenmeier, H., Marsh, J.C., Stromeyer, P., Muller, H., Heimpel, H., Gordon-Smith, E.C. & Ragavacher, A. (1995) A phase I/II trial of recombinant human interleukin-6 in patients with aplastic anaemia. British Journal of Haematology, 90, 283-292.
26. Smith, J.W., Longo, D.L., Alvord, W.G., Janik, J., Sharfman, W.H., Gause B.L., Curti, B.D., Creekmore, S.P., Holmlund, J.T. & Fenton, R.G. (1993) The effects of treatment with interleukin-1 alpha on platelet recovery after high-dose carboplatin. New England Journal of Medicine, 328, 756-761.
27. Wendling, F., Maraskovsky, E., Debili, N, Florindo, C., Teepe, M., Titeux, M., Methia, N., Breton-Gorius, J., Cosman, D. & Vainchechenker, W. (1994) C-Mpl ligand is a humoral regulator of megakaryocytopoiesis. Nature, 369, 571-574.
28. Zeigler, F.C., de Sauvage, F., Widmer, H.R., Keller, G.A., Donahue, C., Schreiber, R.D., Malloy, B., Hass, P., Eaton, D. & Matthews, W. (1994) In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hemopoietic stem cells. Blood, 84, 4045-4052.